Incidental Mutation 'R0324:Aatf'
ID 26373
Institutional Source Beutler Lab
Gene Symbol Aatf
Ensembl Gene ENSMUSG00000018697
Gene Name apoptosis antagonizing transcription factor
Synonyms 5830465M17Rik, Trb, 4933415H02Rik, Che-1
MMRRC Submission 038534-MU
Accession Numbers
Essential gene? Essential (E-score: 1.000) question?
Stock # R0324 (G1)
Quality Score 225
Status Not validated
Chromosome 11
Chromosomal Location 84313681-84404348 bp(-) (GRCm39)
Type of Mutation critical splice donor site (2 bp from exon)
DNA Base Change (assembly) A to G at 84402965 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change
Ref Sequence ENSEMBL: ENSMUSP00000018841 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000018841]
AlphaFold Q9JKX4
Predicted Effect probably null
Transcript: ENSMUST00000018841
SMART Domains Protein: ENSMUSP00000018841
Gene: ENSMUSG00000018697

DomainStartEndE-ValueType
low complexity region 2 35 N/A INTRINSIC
low complexity region 91 119 N/A INTRINSIC
low complexity region 130 173 N/A INTRINSIC
Pfam:AATF-Che1 187 339 4.6e-40 PFAM
low complexity region 418 429 N/A INTRINSIC
Pfam:TRAUB 430 514 3.2e-29 PFAM
Predicted Effect noncoding transcript
Transcript: ENSMUST00000148434
Coding Region Coverage
  • 1x: 99.0%
  • 3x: 98.1%
  • 10x: 96.1%
  • 20x: 93.1%
Validation Efficiency
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] The protein encoded by this gene was identified on the basis of its interaction with MAP3K12/DLK, a protein kinase known to be involved in the induction of cell apoptosis. This gene product contains a leucine zipper, which is a characteristic motif of transcription factors, and was shown to exhibit strong transactivation activity when fused to Gal4 DNA binding domain. Overexpression of this gene interfered with MAP3K12 induced apoptosis. [provided by RefSeq, Jul 2008]
PHENOTYPE: Homozygous embryos do not develop past the compacted morula stage, and after failing to maintain compaction. Mutant embryos show abnormal morphology at E3.5, with most not forming a blastocoel cavity. Severely reduced cell proliferation is observed before blastocyst formation. [provided by MGI curators]
Allele List at MGI

All alleles(20) : Targeted(2) Gene trapped(18

Other mutations in this stock
Total: 76 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
1700010I14Rik T C 17: 9,219,989 (GRCm39) L357S probably benign Het
1700129C05Rik C T 14: 59,380,256 (GRCm39) R14H probably damaging Het
Abca13 T A 11: 9,247,669 (GRCm39) M2472K possibly damaging Het
Abcd3 C A 3: 121,562,816 (GRCm39) Q540H probably null Het
Adam17 C T 12: 21,399,939 (GRCm39) V156I probably benign Het
Adam26a A G 8: 44,021,490 (GRCm39) S667P probably benign Het
Adcy10 A G 1: 165,391,818 (GRCm39) K1333E probably benign Het
Apob G A 12: 8,060,521 (GRCm39) R2968Q probably benign Het
Arap3 G A 18: 38,106,278 (GRCm39) P1522S possibly damaging Het
Catsper1 A T 19: 5,386,573 (GRCm39) S269C probably damaging Het
Cd209d A T 8: 3,928,258 (GRCm39) S42R probably benign Het
Cntln T A 4: 85,010,932 (GRCm39) V1049E probably damaging Het
Cracr2b T C 7: 141,043,659 (GRCm39) F87L probably damaging Het
Crb3 T C 17: 57,372,133 (GRCm39) L60P probably damaging Het
Crispld1 T C 1: 17,819,815 (GRCm39) V271A probably benign Het
Cyp2c66 G T 19: 39,165,135 (GRCm39) R372L probably benign Het
Deup1 G A 9: 15,493,829 (GRCm39) R438W probably benign Het
Dnah6 C T 6: 73,150,541 (GRCm39) E741K possibly damaging Het
Epha4 T C 1: 77,360,188 (GRCm39) E703G probably damaging Het
Evc2 G A 5: 37,550,443 (GRCm39) R819H probably damaging Het
Fam217a A C 13: 35,094,944 (GRCm39) C272G possibly damaging Het
Fndc7 T C 3: 108,784,015 (GRCm39) probably null Het
Foxs1 C T 2: 152,774,607 (GRCm39) G149S probably benign Het
Galnt13 T C 2: 54,744,628 (GRCm39) V109A probably benign Het
Hmgxb4 G A 8: 75,725,556 (GRCm39) M7I probably benign Het
Klk1b1 T A 7: 43,620,165 (GRCm39) C209* probably null Het
Klra10 A G 6: 130,249,613 (GRCm39) probably null Het
Kntc1 A T 5: 123,916,175 (GRCm39) K701N probably damaging Het
Lpgat1 T A 1: 191,481,754 (GRCm39) L114Q probably damaging Het
Mecom T A 3: 30,017,261 (GRCm39) Q468L probably damaging Het
Med15 T C 16: 17,515,476 (GRCm39) T70A probably damaging Het
Msh6 T A 17: 88,294,048 (GRCm39) Y934* probably null Het
Mtus1 T C 8: 41,537,432 (GRCm39) T95A probably benign Het
Mylk3 C A 8: 86,079,535 (GRCm39) R444S probably damaging Het
Nbea A G 3: 55,965,369 (GRCm39) probably null Het
Nbeal1 T C 1: 60,332,032 (GRCm39) V2242A probably damaging Het
Nhp2 A G 11: 51,513,334 (GRCm39) T85A possibly damaging Het
Nlk A G 11: 78,463,257 (GRCm39) S413P possibly damaging Het
Nmbr A G 10: 14,636,192 (GRCm39) I54V possibly damaging Het
Nmur2 A T 11: 55,931,346 (GRCm39) C122S probably damaging Het
Nudt13 G T 14: 20,361,583 (GRCm39) V220L probably damaging Het
Or5m13 G A 2: 85,748,295 (GRCm39) V9M probably benign Het
Pclo G A 5: 14,719,447 (GRCm39) G1195R unknown Het
Pcsk7 A G 9: 45,824,309 (GRCm39) H276R possibly damaging Het
Pdss2 T C 10: 43,269,924 (GRCm39) S256P probably damaging Het
Pgf G T 12: 85,218,198 (GRCm39) H116N probably benign Het
Pglyrp2 T C 17: 32,637,302 (GRCm39) D242G probably benign Het
Plk2 G A 13: 110,534,242 (GRCm39) R274K probably benign Het
Ppp6r3 G T 19: 3,514,693 (GRCm39) P141T probably benign Het
Prss54 T C 8: 96,292,295 (GRCm39) T95A probably benign Het
Rab3il1 A G 19: 10,005,653 (GRCm39) D149G probably damaging Het
Rasgef1c T C 11: 49,852,057 (GRCm39) probably null Het
Rhpn1 T C 15: 75,583,437 (GRCm39) M334T probably damaging Het
Rigi T C 4: 40,213,766 (GRCm39) T586A probably benign Het
Robo2 C T 16: 73,764,739 (GRCm39) V630M probably damaging Het
Rptor C T 11: 119,783,467 (GRCm39) R1154W probably damaging Het
Scnn1g A G 7: 121,339,778 (GRCm39) I192M possibly damaging Het
Sit1 G A 4: 43,482,815 (GRCm39) Q115* probably null Het
Slc13a2 T C 11: 78,295,350 (GRCm39) N141S probably damaging Het
Slc19a2 C A 1: 164,084,344 (GRCm39) T78K probably damaging Het
Snx14 A G 9: 88,287,291 (GRCm39) probably null Het
Stil T A 4: 114,896,346 (GRCm39) C944S probably benign Het
Tex56 A G 13: 35,108,596 (GRCm39) N26S probably benign Het
Tnfaip2 A G 12: 111,419,893 (GRCm39) N675S probably damaging Het
Trim30c A G 7: 104,032,516 (GRCm39) I270T possibly damaging Het
Ugt2a3 C T 5: 87,474,932 (GRCm39) probably null Het
Vmn1r213 A T 13: 23,195,588 (GRCm39) probably benign Het
Vmn2r8 A C 5: 108,945,807 (GRCm39) probably null Het
Vps13c T C 9: 67,871,591 (GRCm39) F3253L possibly damaging Het
Zbtb16 G T 9: 48,576,575 (GRCm39) Q502K possibly damaging Het
Zfp143 A G 7: 109,676,354 (GRCm39) K218E possibly damaging Het
Zfp946 A G 17: 22,673,417 (GRCm39) N57S probably benign Het
Zfp985 T C 4: 147,667,314 (GRCm39) Y61H probably benign Het
Zkscan1 G A 5: 138,095,785 (GRCm39) R246Q probably damaging Het
Zpld1 A G 16: 55,071,978 (GRCm39) F94L probably damaging Het
Zswim5 G T 4: 116,844,103 (GRCm39) W1047L probably damaging Het
Other mutations in Aatf
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL00900:Aatf APN 11 84,361,383 (GRCm39) splice site probably benign
IGL01482:Aatf APN 11 84,361,536 (GRCm39) missense possibly damaging 0.51
IGL01775:Aatf APN 11 84,361,963 (GRCm39) missense probably damaging 1.00
IGL02881:Aatf APN 11 84,362,115 (GRCm39) splice site probably benign
R0183:Aatf UTSW 11 84,401,251 (GRCm39) splice site probably null
R0200:Aatf UTSW 11 84,336,502 (GRCm39) missense probably damaging 1.00
R0257:Aatf UTSW 11 84,401,107 (GRCm39) missense probably benign 0.33
R0494:Aatf UTSW 11 84,402,339 (GRCm39) missense probably benign
R0544:Aatf UTSW 11 84,313,831 (GRCm39) missense probably benign 0.09
R1186:Aatf UTSW 11 84,361,375 (GRCm39) splice site probably benign
R2339:Aatf UTSW 11 84,402,323 (GRCm39) missense probably benign 0.00
R4626:Aatf UTSW 11 84,313,784 (GRCm39) makesense probably null
R4647:Aatf UTSW 11 84,362,023 (GRCm39) missense possibly damaging 0.69
R4697:Aatf UTSW 11 84,339,964 (GRCm39) missense probably damaging 1.00
R4981:Aatf UTSW 11 84,402,323 (GRCm39) missense probably benign 0.00
R5490:Aatf UTSW 11 84,401,099 (GRCm39) missense probably damaging 1.00
R5938:Aatf UTSW 11 84,333,400 (GRCm39) missense possibly damaging 0.88
R6267:Aatf UTSW 11 84,363,926 (GRCm39) missense probably benign 0.09
R6296:Aatf UTSW 11 84,363,926 (GRCm39) missense probably benign 0.09
R6633:Aatf UTSW 11 84,402,308 (GRCm39) critical splice donor site probably null
R7081:Aatf UTSW 11 84,361,951 (GRCm39) missense possibly damaging 0.84
R7212:Aatf UTSW 11 84,340,006 (GRCm39) missense probably damaging 0.98
R7545:Aatf UTSW 11 84,361,502 (GRCm39) missense probably benign 0.04
R7754:Aatf UTSW 11 84,402,335 (GRCm39) missense possibly damaging 0.53
R7871:Aatf UTSW 11 84,361,864 (GRCm39) frame shift probably null
R8411:Aatf UTSW 11 84,361,502 (GRCm39) missense probably benign 0.04
R8746:Aatf UTSW 11 84,402,338 (GRCm39) missense probably benign 0.06
R9406:Aatf UTSW 11 84,361,866 (GRCm39) frame shift probably null
X0018:Aatf UTSW 11 84,401,211 (GRCm39) missense possibly damaging 0.85
Z1176:Aatf UTSW 11 84,333,411 (GRCm39) missense probably benign 0.01
Predicted Primers PCR Primer
(F):5'- ACCAGGCCACATCTTTCATTCCAG -3'
(R):5'- GCCACTAGAGCCAGAGTGATTGAC -3'

Sequencing Primer
(F):5'- agccatctctccagccc -3'
(R):5'- CCAGAGTGATTGACAGGTTTGATG -3'
Protein Function and Prediction

Aatf encodes apoptosis-antagonizing transcription factor (AATF; alternatively Che-1 or Traube (Trb)), a nuclear protein that regulates gene transcription and cell proliferation. AATF has a leucine zipper motif, three nuclear receptor-binding LxxLL consensus sequences, and two N-terminal acidic domains (1;2). AATF is essential for preimplantation development.

Expression/Localization

AATF is expressed at high levels in the heart, skeletal muscle, and testis, and at lower levels in all other tissues analyzed (1-3). In the mouse Aatf is ubiquitously expressed early in development; expression is restricted to the liver and central nervous system from embryonic day (E)11.5 onward (4). The AATF protein is localized to the nucleus and the nucleoli (4).

Background

AATF is an interacting protein for RNA polymerase II. In addition, AATF counteracts Rb repression to facilitate E2F-dependent transactivation during G1-S transition. AATF also functions in the DNA damage response and cell-cycle checkpoint control. AATF is an adaptor that connects transcriptional regulation, cell-cycle progression, checkpoint control, and apoptosis [reviewed in (5)].

 

AatfGt(pGT1.8geo)3Pgr/Gt(pGT1.8geo)3Pgr; MGI:2176283

Genetic background: either: (involves: 129/Sv * C57BL/6) or (involves: 129/Sv * NMRI)
Homozygous embryos do not develop past the compacted morula stage, and after failing to maintain compaction (4). Mutant embryos show abnormal morphology at E3.5, with most not forming a blastocoel cavity (4). Severely reduced cell proliferation is observed before blastocyst formation (4). Homozygous embryos also exhibit 50% reduction in total cell number resulting in decreased embryo size (4).

References
Posted On 2013-04-16
Science Writer Anne Murray